Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
about
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions.KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy.Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy.Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer.Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report.Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer.Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors.CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype.Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors.Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma.WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer.Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments.Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment.Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer.Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.Pancreatic cancer survival analysis defines a signature that predicts outcomeMedullary carcinoma of the pancreas radiologically followed up as a cystic lesion for 9 years: a case report and review of the literaturePancreatic cancer subtypes: a roadmap for precision medicineComprehensive Validation of Snapback Primer-Based Melting Curve Analysis to Detect Nucleotide Variation in the Codon 12 and 13 of KRAS GeneIntegrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomasPrognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomyIntrapancreatic recurrence of intraductal tubulopapillary neoplasm (ITPN) 16 years after the initial surgery for noninvasive ITPN: a case reportGenome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyUtility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patientsEpithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancerIntegrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinomaPancreatic cancer foiled by a switch of tumour subtype
P2860
Q45944020-0F9A751D-6787-435D-8E1B-93ECBBDBDB7DQ46471150-2777418D-D78F-475F-8342-0FE6DB57B3ADQ47209071-B0F166B4-3A56-4BDF-BBBC-7CEDE3C5030AQ47232401-CF41242D-E92E-4306-8512-777EFD0C5F30Q47735303-E9C8352A-36D0-4545-832A-B8E0A1364E52Q48141138-CB03778A-5EF1-4F6E-808B-41B188109C9AQ48163413-2DB99799-8102-4B4A-A547-778111401A53Q49487531-CEEA00E1-9B6F-4E6D-86A1-E5644CFB3F8BQ49547506-BCCF7834-E125-4368-8F33-A4FA07ACD0CBQ50057521-C90C951B-F7F3-485A-8DFD-66A1B29A44C7Q50112183-3F1D3814-A911-45C7-A72B-3142A6FC6A04Q52357490-EE4FC47D-CA17-449E-9698-97732A177CC8Q53069544-CF843AC9-C036-4615-AE73-6AFBF8E3768AQ54952243-1FDA3690-87D0-4A9E-B889-400343DF529EQ54957880-76E0BBDA-6646-4679-B9A4-7DECBEAA2698Q54977769-3B5DC6C6-D0A8-40FA-B438-216B5E61E07DQ54980764-0F5E6135-254F-4C67-A5F8-019FE0794D10Q54986110-D2A4CA73-2847-44CB-8062-AB1200D772D2Q55080593-DF61F5A7-4676-404B-B36F-59760F55796CQ55104265-01B7FB31-C70A-4922-AB94-88B107EBD88CQ55114944-A48460B0-6D8A-4E46-9739-56F40111E013Q55262428-6BBB9CE5-44DF-4BB4-97AD-1AFC53C48175Q55424250-A122D99E-E4CE-4077-A8AE-AAC597A2A72CQ57136038-1C4EBFB2-5023-4FF0-A722-9DDD4E793D77Q57174976-6DB56F89-707E-4A43-87EB-12C6EB476AA9Q58146806-374CD882-3CD6-40A6-8AE8-EEC07B861E5AQ58575063-6158BEC3-5AEF-4171-B9B2-E4F6B0ED9B42Q58711412-CCC98825-7D3A-4049-A4A6-87807B768F76Q58763050-CA77C434-3EF7-4C61-BE56-B156595F7514Q58774396-E9A87702-1D47-4397-8D5B-9FE00FD062C2Q58790645-6C283025-73B3-4B34-A0C7-1224C19DC09DQ58803568-84460AAA-616F-498E-A811-6F6E4C6FD3E6Q59126765-C59229BD-03F4-4A64-81B7-DA5DD7902984Q59127131-3B0A5848-E2B6-4DA6-A423-894F00BFE211Q74441820-42CAB2D1-C18C-4F32-83C5-9231D5212646
P2860
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
@en
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
@nl
type
label
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
@en
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
@nl
prefLabel
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
@en
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
@nl
P2860
P1433
P1476
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
@en
P2093
Cancer Genome Atlas Research Network
Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu
P2860
P304
185-203.e13
P356
10.1016/J.CCELL.2017.07.007
P577
2017-08-01T00:00:00Z